Miacalcin and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Miacalcin (calcitonin, salmon), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Prilosec, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Miacalcin. It is created by eHealthMe based on reports of 5,414 people who have side effects when taking Miacalcin from the FDA, and is updated regularly.

What is Miacalcin?

Miacalcin has active ingredients of calcitonin, salmon. It is often used in osteoporosis. eHealthMe is studying from 5,437 Miacalcin users. Check the latest studies of Miacalcin.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,524 drugs and 4,592 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 05, 2026

5,414 people reported to have side effects when taking Miacalcin.
Among them, 91 people (1.68%) have Appetite - decreased.

Could Miacalcin cause Appetite - decreased?

Among these 91 people:

How long have people been on Miacalcin when they have Appetite - decreased? *

What is the gender of people who have Appetite - decreased when taking Miacalcin? *

female: 85.23 %
male: 14.77 %

What is the age of people who have Appetite - decreased when taking Miacalcin? *

What are other drugs people take besides Miacalcin? *

What are other side effects people have besides Appetite - decreased? *

Fatigue (feeling of tiredness): 45 people, 49.45%
Pain: 44 people, 48.35%
Stress And Anxiety: 44 people, 48.35%
Diarrhea: 42 people, 46.15%
Fall: 38 people, 41.76%
Nausea (feeling of having an urge to vomit): 37 people, 40.66%
Weakness: 35 people, 38.46%
Constipation: 35 people, 38.46%
Malaise (a feeling of general discomfort or uneasiness): 34 people, 37.36%
Tremor (trembling or shaking movements in one or more parts of your body): 33 people, 36.26%

What are the existing conditions these people have? *

Stress And Anxiety: 9 people, 9.89%
Pain: 8 people, 8.79%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 4.40%
Neuropathy Peripheral (surface nerve damage): 4 people, 4.40%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 4.40%
Jugular Vein Thrombosis (clot in jugular vein): 4 people, 4.40%
Migraine (headache): 4 people, 4.40%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 4.40%
Neoplasm Malignant (cancer tumour): 3 people, 3.30%
Pancreatic Disorder: 3 people, 3.30%

* Approximation only. Some reports may have incomplete information.

Do you take Miacalcin and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Miacalcin:

Miacalcin (5,437 reports)

Browse all side effects of Miacalcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,524 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,592 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitonin, salmon (the active ingredients of Miacalcin) and Miacalcin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.